|
[About AIDScience articles] [NeuroAIDS articles]
|
Raising new barriers against HIV infection (Perspective)
By Rebecca Spieler Trager
|
Reflections on HIV prevention strategies in the United States in 2002 (Perspective)
By David R. Holtgrave
|
The need to understand vaccine demand (Perspective)
By Emily Bass, from the IAVI Report
|
Discovering the cause of AIDS (Perspective)
By Stanley B. Prusiner
|
A history of HIV discovery (Perspective)
By Luc Montagnier
|
The early years of HIV/AIDS (Perspective)
By Robert C. Gallo
|
Enhanced: Prospects for the future (Perspective)
By Robert C. Gallo and Luc Montagnier
|
Protective immunity in HIV-1-exposed, persistently seronegative subjects (Perspective)
Q & A mini review by Claudia Devito
|
Barcelona sessions spark full discussion of partially effective vaccines (Perspective)
By Emily Bass, from the IAVI Report
|
Superinfection: What does it mean for vaccines? (Perspective)
By Patricia Kahn, from the IAVI Report
|
Anti-R7V antibodies may protect some HIV-infected patients from developing AIDS: A conversation with Jean-Claude Chermann (Perspective)
Interview with Jean-Claude Chermann
|
Contribution of human a-defensin-1, -2 and -3 to the anti-HIV-1 activity of CD8 antiviral factor (Report)
By Linqi Zhang, Wenjie Yu, Tian He, Jian Yu, Rebecca E. Caffrey, Enrique A. Dalmasso, Siyu Fu, Thang Pham, Jianfeng Mei, Jaclyn J. Ho, Wenyong Zhang, Peter Lopez, and David D. Ho
|
Mystery anti-HIV factor unmasked? (Perspective)
By Jon Cohen
|
Broadly cross-reactive anti-HIV neutralizing antibodies: A conversation with Robert Gallo (Perspective)
Interview with Robert Gallo
|
Learning from microbicides: A young field's experience working with high-risk women (Perspective)
By Emily Bass, from the IAVI Report
|
HIV/AIDS: Malawi: A suitable case for treatment (Perspective)
By Jon Cohen
|
HIV/AIDS MEETING: Tough challenges ahead on political and scientific fronts (Perspective)
By Jon Cohen
|
Injecting drug users and HIV vaccine trials: What does the science say? (Perspective)
By Chris Beyrer
|
Review: Diversity considerations in HIV-1 vaccine selection (Report)
By Brian Gaschen, et al.
|
Policy Forum: China and AIDS—The time to act is now (Perspective)
By Joan Kaufman and Jun Jing
|
Letter: HIV-1 diversity and vaccine development (Perspective)
By Gary Nabel, et al.
|
VACCINES: Monkey puzzles (Perspective)
By Jon Cohen
|
THERAPIES: Confronting the limits of success (Perspective)
By Jon Cohen
|
Insights into HIV-specific CD4+ T cell immunity (Perspective)
By Ronald B. Moss
|
"Natural" resistance to HIV: Is the evidence good enough to design an effective vaccine? (Report)
By Paul Palumbo, Joan Skurnick, Christine Rohowsky-Kochan, and Donald Louria
|
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level (Report)
By Corey B. Moore, Mina John, Ian R. James, Frank T. Christiansen, Campbell S. Witt, Simon A. Mallal
|
HLA leaves its footprints on HIV (Perspective)
By Andrew McMichael and Paul Klenerman
|
Paradigm shift for HIV prevention in the United States (Perspective)
By Gordon Mansergh
|
Warming trends at Keystone vaccine conference (Perspective)
By Emily Bass and Richard Jefferys, from the IAVI Report
|
Development of the dual-subtype feline immunodeficiency virus vaccine (Report)
By Janet K. Yamamoto, Barbara A. Torres and Ruiyu Pu
|
Eat your corn flakes—and get vaccinated? (Perspective)
Interview with John Howard, from ProdiGene Inc.
|
Retrovirus 2002: Merck debuts phase I data (Perspective)
By Richard Jefferys and Emily Bass, from the IAVI Report
|
No hope for an AIDS vaccine soon (Perspective)
By Heinz Köhler, Sybille Müller, and Veljko Veljkovic
|
Advances in the prevention of mother-to-child HIV-1 transmission: current issues, future challenges (Report)
By Marc Bulterys, Monica L. Nolan, Denise J. Jamieson, Kenneth Dominguez and Mary Glenn Fowler
|
AIDS and vaccine development in Asia (Perspective)
By Patricia Kahn and Ian Grubb
|
Implications for HIV prevention programs of the 11 September 2001 terrorist attacks on the United States (Perspective)
By David R. Holtgrave
|
Microbicides to prevent heterosexual transmission of HIV: Ten years down the road (Report)
By Janneke van de Wijgert and Christiana Coggins
|
|
[About AIDScience articles] [NeuroAIDS articles]
|
